Medicines Distribution Consents




3396 NEW ZEALAND GAZETTE No. 126

Product:
Macleans Ice Advanced Whitening
Active Ingredient:
Sodium fluoride 0.221%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Australia Pty Limited, Ermington, New South Wales, Australia
Dated this 31st day of August 2003.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go5845


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Nurofen Caplet
Active Ingredient:
Ibuprofen 200mg
Dosage Form:
Coated tablet
New Zealand Sponsor:
Boots Healthcare New Zealand Limited
Manufacturer:
The Boots Company Plc, Beeston, Nottingham, United Kingdom

Product:
Nurofen
Active Ingredient:
Ibuprofen 200mg
Dosage Form:
Coated tablet
New Zealand Sponsor:
Boots Healthcare New Zealand Limited
Manufacturer:
The Boots Company Plc, Beeston, Nottingham, United Kingdom

Product:
Quadracel
Active Ingredients:
Adsorbed tetanus vaccine 5Lf U
Diphtheria toxoid, adsorbed 15Lf U
Pertactin 3µg
Pertussis filamentous haemagglutinin 20µg
Pertussis fimbriae 2+3 5µg
Pertussis toxoid, adsorbed 20µg
Polio virus type 1 40DAgU
Polio virus type 2 8DAgU
Polio virus type 3 32DAgU
Dosage Form:
Suspension for injection
New Zealand Sponsor:
Aventis Pharma Limited
Manufacturer:
Aventis Pasteur Limited, North York, Ontario, Canada

Dated this 31st day of August 2003.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go5844


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Dysport
Active Ingredient:
Clostridium botulinum type A toxin haemagglutinin complex 500U
Dosage Form:
Powder for injection
New Zealand Sponsor:
New Zealand Medical & Scientific Limited
Manufacturer:
Ispen Limited, Clwyd, United Kingdom

Product:
Lescol XL
Active Ingredient:
Fluvastatin sodium 84.24mg equivalent to 80mg fluvastatin
Dosage Form:
Modified release tablet
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Novartis Pharma Stein AG, Stein, Switzerland



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2003, No 126


Gazette.govt.nz PDF NZ Gazette 2003, No 126





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Related Products

🏥 Health & Social Welfare
31 August 2003
Medicines, Distribution, Medicines Act 1981, Macleans Ice Advanced Whitening
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
31 August 2003
Medicines, Distribution, Medicines Act 1981, Nurofen, Quadracel
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
31 August 2003
Medicines, Distribution, Medicines Act 1981, Dysport, Lescol XL
  • DON MATHESON, Deputy Director-General, Public Health